BM-MSCs demonstrate superior chondrogenic and osteogenic differentiation potential compared to AD-MSCs, attributable to their higher expression of TGFβ1 [200–203], whereas AD-MSCs express higher HGF than BM-MSCs [204], corresponding with their enhanced proliferative potential and immunomodulatory capacity [203]. The gene discussed is HGF; the disease is Alzheimer disease.